Hellenic Dynamics PLC Notice of AGM (6369L)

TIDMHELD

RNS Number : 6369L

Hellenic Dynamics PLC

07 September 2023

7 September 2023

Hellenic Dynamics plc

("Hellenic Dynamics" or the "Company")

Notice of Annual General Meeting and Form of Proxy

Hellenic Dynamics Plc (LSE: HELD), a medical cannabis cultivator specifically focused on the cultivation and supply of tetrahydrocannabinol dominant strains of medical cannabis flowers destined for the rapidly growing medical cannabis markets across Europe, announces that its Notice of Annual General Meeting ("AGM") and Form of Proxy ("Proxy") were posted to shareholders on 6 September 2023.

Both the Notice of AGM and the Proxy will shortly be uploaded to the National Storage Mechanism and will be available at: www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism .

These documents, as well as the Annual Report for year ended 31 March 2023, are also available on the Company's website at: https://www.hellenicdynamics.com .

The AGM will be held on 29 September 2023 at 13:00 at the offices of Shakespeare Martineau, 6(th) floor, 60 Gracechurch Street, London, EC3V 0HR.

The Directors of the Company take responsibility for the contents of this announcement.

Enquires:

   Hellenic Dynamics plc                                [phone] 
   Davinder Rai                                                [e-mail] 

Cairn Financial Advisers LLP

   Emily Staples / Jo Turner                           [phone] 

Peterhouse Capital

   Lucy Williams / Charles Goodfellow        [phone] 

J&H Communications

   George Hudson                                           [phone] 

About Hellenic Dynamics plc

Founded in 2019, Hellenic Dynamics is specifically focused on the cultivation and supply of tetrahydrocannabinol ("THC") - dominant strains of medical cannabis flowers, destined for the growing medical cannabis markets across Europe. Hellenic Dynamics' core strategy is to develop and operate its 40,000 square metre active cultivation licence from its 195,506 square metre facility located near Thessaloniki in Northern Greece. In full production, Hellenic Dynamics is capable of producing over 54,000 kg of dried flowers per annum.

Hellenic Dynamics will take advantage of its relatively low cost base resulting from a comparatively low cost of power, having its own running water supply and the labour rates for skilled and semi-skilled labour in Northern Greece.

25 European countries now allow medical cannabis via prescription and the European cannabis market is expected to reach EUR43.3 billion per annum by 2027. Sales of Hellenic Dynamics' dried THC-dominant cannabis flowers and extracts are initially intended for export into Europe's largest market - Germany, in addition to other European markets including domestically in Greece.

As the first medical cannabis cultivator to obtain a listing on the main market for listed securities of the London Stock Exchange, Hellenic is significantly different to the number of CBD (Cannabidiol) related companies that have appeared over the recent years. Hellenic Dynamics cultivates THC-dominant medical cannabis flowers. THC-dominant medical cannabis products are only available via a medical prescription. Medicinal cannabis has been approved for use both in the United Kingdom and Germany, plus 23 other European countries, for conditions including but not limited to chronic pain, intractable chemotherapy-related nausea, anxiety, insomnia, Tourette's syndrome, substance use disorder, multiple sclerosis, IBS, spinal cord treatment, lack of appetite due to HIV/AIDS, cachexia, anorexia and glaucoma.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOALFMMTMTBMTRJ

(END) Dow Jones Newswires

September 07, 2023 02:00 ET (06:00 GMT)